Upstream Bio, Inc. (UPB) earnings
UPB earnings moved a median of +1.50% by the close. Quarterly and annual UPB reports and results, each read against the price at its own news timestamp. Back to the UPB overview →
14 measured UPB earnings events.
Where these UPB earnings landedvs 14 measured UPB earnings reactions
| Middle 50% of UPB earnings reactions | -4.96% to +4.46% |
|---|---|
| Median reaction (to close) | +1.50% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 UPB earnings events with a measured close landed between -4.96% and +4.46%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Upstream Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.94% | -5.21% | |
| Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress | Press release | -0.94% | -5.21% | |
| Form 10-Q Upstream Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +4.46% | |
| Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights | Press release | +0.00% | +4.46% | |
| Form 10-K Upstream Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.86% | -0.57% | |
| Form 10-Q Upstream Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.15% | -5.78% | |
| Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress | Press release | -4.15% | -5.78% | |
| Form 10-Q Upstream Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.26% | +10.07% | |
| Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress | Press release | +0.26% | +10.07% | |
| Form 10-Q Upstream Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -4.20% | |
| Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs | Press release | +0.00% | -4.20% | |
| Form 10-K Upstream Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.07% | +5.97% | |
| Form 10-Q Upstream Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.03% | +3.56% | |
| Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | +1.03% | +3.56% |
Keep exploring
More UPB: analyst actions → · SEC filings → · UPB overview →